Dextrose Monohydrate 50% Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dextrose Monohydrate 50% Injection (injection) from Hospira, Inc., A Pfizer Company with status No longer listed by FDA. The shortage was first posted on Nov 7, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-4902-34
- Dosage Form
- Injection
- Presentation
- Dextrose Monohydrate 50%, Injection, 50% Dextrose Injection 0.5 g/mL; ABBOJECT® Glass Syringe (NDC 0409-4902-34)
- Initial Posting
- Nov 7, 2025